French parliament passes motion condemning China ‘genocide’ against Uyghurs
Paris (Reuters) – France’s parliament passed an opposition-led motion asking the government to condemn China for “crimes against humanity and
Read More
Factual Version of a Story
Latest
Ex-Pope Benedict accused of failing to act in Munich Church abuse report
Berlin (Reuters) – Former Pope Benedict XVI failed to take action against clerics in four cases of alleged sexual abuse
Read More
Europe threatens ‘massive’ sanctions if Russia attacks Ukraine
Berlin (Reuters) – The European Union threatened “massive” economic sanctions if Moscow attacks Ukraine, and U.S. Secretary of State Antony
Read More
Dozens of firms to make cheap version of Merck COVID pill for poorer nations
Brussels (Reuters) – A U.N.-backed agency has struck a deal for nearly 30 generic drugmakers to make low-cost versions of
Read More
Bomb blast kills 3 people in eastern Pakistan – police
Lahore (Reuters) – A bomb blast ripped through a crowded market in eastern Pakistan on Thursday, killing three people and
Read More
Omicron poses limited downside to Indian economy, say economists
New Delhi (Reuters) – There is scant downside risk to the Indian economy in the last months of this financial
Read More
Afghan acting PM calls for official recognition of Taliban administration
Kabul (Reuters) – Afghanistan’s acting prime minister, Mullah Hasan Akhund, on Wednesday called for international governments to officially recognise the
Read More
Breivik as dangerous now as a decade ago: psychiatrist
Oslo (Norway) AFP – Anders Behring Breivik, who is seeking conditional release just 10 years after carrying out Norway’s deadliest
Read More
Kazakhstan president fires defence minister for lack of leadership during protests
Almaty (Reuters) – Kazakhstan’s President Kassym-Jomart Tokayev fired his defence minister on Wednesday, accusing him of failing to show leadership
Read More
India’s expert panel advises full approval for Covishield, Covaxin
New Delhi (Reuters) – The Indian drug regulator’s subject expert committee on Wednesday recommended full approval for Covishield and Covaxin,
Read More